4
Changes in Ownership
TherapeuticsMD, Inc. Filed Acc 0001209191-21-058498
Options or other derivatives
- CAO and VP of Finance acquired 38,954 shares (grant or award)
- CAO and VP of Finance disposed of 290,000 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Donegan Michael C · CAO and VP of Finance
Table II: Derivative
5 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-09-29 | Grant or award : show line 1 in the form Restricted Stock Units | +38,954 | 38,954 | D |
| 2021-09-29 | Other disposition : show line 2 in the form Non-Qualified Stock Option (right to buy) | −50,000 | 0 | D |
| 2021-09-29 | Other disposition : show line 3 in the form Non-Qualified Stock Option (right to buy) | −100,000 | 0 | D |
| 2021-09-29 | Other disposition : show line 4 in the form Non-Qualified Stock Option (right to buy) | −40,000 | 0 | D |
| 2021-09-29 | Other disposition : show line 5 in the form Non-Qualified Stock Option (right to buy) | −100,000 | 0 | D |
Loading xslF345X03/doc4.xml…